|Biotage AB -- USA Stock|| |
USD 9.95 0.00 0.00%
Chairman of the Board of Directors
Mr. Ove H. Mattsson was Chairman of the Board of Directors of Biotage AB since April 27, 2007. He was on the Companys Board for fourteen years serving as its Chairman until 2006. Mr. Mattsson is Management Consultant. He also serves as Board Member at Vironova Medical AB and Vironova AB. He is also Member of the Royal Swedish Academy of Engineering Sciences
Age: 76 Chairman Since 2007 Ph.D
46 18 56 59 00 http://www.biotage.com
Mattsson has obtained a Doctorate of Philosophy degree and is Associate Professor in Organic Chemistry.
The company has return on total asset (ROA)
of 11.14 %
which means that it generated profit of $11.14 on every $100 spent on asset. This is normal as compared to the sector avarege. Similarly, it shows return on equity (ROE)
of 22.38 %
meaning that it generated $22.38 on every $100 dollars invested by stockholders.
Biotage AB , a life science company, offer solutions, knowledge, and experience in the areas of analytical chemistry, medicinal chemistry, peptide synthesis, separation, and purification in the United States, Europe, and Japan. Biotage AB (BITGF) is traded on OTC Market in USA. It is located in Uppsala, and employs 319 people.